Hims(US:HIMS) Prnewswireยท2025-07-17 21:59Core Viewpoint - Securities class action lawsuits have been filed against Hims & Hers Health, Inc. for allegedly making false and misleading statements regarding the company's business practices and safety concerns during the specified class period [1][3]. Group 1: Legal Proceedings - The lawsuits were filed in the United States District Court for the Northern District of California on behalf of investors who acquired Hims & Hers securities between April 29, 2025, and June 23, 2025 [1]. - The deadline for lead plaintiffs to be appointed is August 25, 2025 [1][4]. Group 2: Allegations Against Hims & Hers - Defendants are accused of failing to disclose that Hims & Hers was involved in the deceptive promotion and sale of illegitimate versions of Wegovy, which posed risks to patient safety [3]. - There is a substantial risk that Hims & Hers' collaboration with Novo Nordisk could be terminated due to these practices [3]. - The positive statements made by the defendants regarding the company's business and prospects are claimed to be materially misleading and lacking a reasonable basis [3]. Group 3: Investor Information - Investors who suffered losses are encouraged to contact Kessler Topaz Meltzer & Check, LLP for more information and to potentially participate in the class action [5]. - The firm has a reputation for prosecuting class actions and has recovered billions for victims of corporate misconduct [5].